To: fred hayes who wrote (1861 ) 5/3/2005 1:04:12 PM From: nigel bates Respond to They weren't publishing the royalty rates at the time of the amended agreement in July last year -a. In consideration for the grant of the license hereunder and other good and valuable consideration, GSK shall pay Corixa a royalty on all Net Sales generated on or after June 30, 2008, which royalty obligation shall expire for all Products, ten (10) years after the first commercial sale in the United States or Europe of GSK's Product for the prevention and/or control and/or treatment of human papilloma virus in humans or fifteen years (15) after the first commercial sale in the United States or Europe of GSK's Product for the prevention and/or control and/or treatment of herpes simplex virus in humans if GSK does not launch a Product for the prevention and/or control and/or treatment of human papilloma virus in humans, provided, however, that if the first commercial sale of such Product occurs after June 30, 2008, GSK shall continue to pay royalties in accordance with the applicable MPL License and Supply Agreement on all Net Sales of other Products until such first commercial sale, after which only the royalty due under this Amendment shall be payable on Net Sales. Aggregate Annual Net Sales of the Mr. Bates:
